Skip to main content

Hypertension and Acute Hypertensive Crisis

  • Chapter
  • First Online:
Medical Management of Psychotropic Side Effects
  • 1189 Accesses

Abstract

Hypertension prevalence is more than 30% in the general population and may be as high as 50% in some populations with mental illness. It is defined using cutoffs for systolic and diastolic blood pressure (SBP and DBP) that vary based on age and certain medical conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2005;66(2):253–9.

    Google Scholar 

  2. Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van Dyck R, et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension. 2009;53(4):631–8.

    Google Scholar 

  3. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry. 1998;59(10):502–8.

    Article  CAS  PubMed  Google Scholar 

  4. Thase ME, Tran PV, Wiltse C, Pangallo BA, Mallinckrodt C, Detke MJ. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharmacol. 2005;25(2):132–40.

    Article  CAS  PubMed  Google Scholar 

  5. Woo YS, Kim W, Chae JH, Yoon BH, Bahk WM. Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients. World J Biol Psychiatry. 2009;10(4 Pt 2):420–5.

    Article  PubMed  Google Scholar 

  6. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Appendix

Appendix

Guidelines from Joint National Commission (JNC-8) [6]

Thiazide diuretics , calcium channel blockers (CCBs) , angiotensin-converting enzyme inhibitors (ACEIs) , or angiotensin receptor blockers (ARBs) are all considered first-line medications for hypertension treatment

For black patients, including those with diabetes, CCBs or thiazide diuretics should be first-line medications

For all patients with chronic kidney disease, regardless of race or diabetes status, ACEIs or ARBs should be included in antihypertensive treatment

Beta blockers should only be considered after thiazine diuretics, CCBs, ACEIs, ARBs, unless other indications like ischemic heart disease or heart failure are present

If BP is not at goal after 1 month on medication, dose should be raised or second agent added; medications should be added until goal BP is reached

figure b

Commonly used medications for hypertension

Medication class

Mechanism of action

Comments

Thiazide diuretics

Hydrochlorothiazide

Chlorthalidone

Inhibit sodium transport in the distal renal tubule

Serum potassium should be monitored

ACEI

Lisinopril

Enalapril

Captopril

Inhibit conversion of angiotensin I to II resulting in vasodilation and reduced sympathetic activity

Renal function and serum potassium should be monitored

ARB

Losartan

Candesartan

Valsartan

Block angiotensin II receptors in blood vessels resulting in vasodilation and reduced sympathetic activity

Generally only indicated if ACEIs are not tolerated (e.g., cough occurs with ACEIs and not ARBs)

CCBs

Dihydropyridine

Amlodipine

Nondihydropyridine

Verapamil

Diltiazem

Regulate calcium influx into vascular smooth muscle cells and reduce vascular resistance

No lab monitoring required

Nondihydropyridines generally used only with additional indications (e.g., atrial fibrillation)

Beta blockers

Metoprolol

Atenolol

Carvedilol

Block beta receptors in blood vessels and reduce sympathetic tone

Not used unless additional indications (e.g., atrial fibrillation, angina, heart failure) and first-line agents already used

Metoprolol and atenolol are cardioselective and preferred in obstructive lung disease

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Annamalai, A. (2017). Hypertension and Acute Hypertensive Crisis. In: Medical Management of Psychotropic Side Effects. Springer, Cham. https://doi.org/10.1007/978-3-319-51026-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51026-2_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51024-8

  • Online ISBN: 978-3-319-51026-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics